Peer-reviewedCC BY-NC-NDJournal of thoracic disease10 Sep 2026

Immune checkpoint inhibitors (ICIs) for second-line retreatment in esophageal cancer progressing after first-line immunotherapy: a single-center retrospective cohort study

Yixin Kang¹
Youjia Mi¹
Ce Zhang¹
Wenyao Li¹
Junqiang Yang¹
Jun Yao¹
Dianbao Zhang¹

¹Department of Gastrointestinal Oncology , The First Affiliated Hospital of Henan University of Science and Technology , Luoyang , ;

971 The impact of liver metastases on immune-related adverse events in stage IV patients treated with immune-checkpoint inhibitors: a real-world, multicenter, retrospective study
Adil Alaoui, Jessica A Catterson, Michael B Atkins +4
Journal for ImmunoTherapy of Cancer4 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ
Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study
Tanja Mueller, Christine Crearie, Liya Lu +7
British Journal of Clinical Pharmacology20 Jul 2026Peer-reviewedCC BY 4.0Full text1 citedOncologyPMC
Efficacy and Safety of Sequential Radiotherapy and Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Single-Center PSM Retrospective Cohort Study.
Huaxi Fan, Rong Yu, Guishu Wu +6
Journal of hepatocellular carcinoma28 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study
Xiaolong Zhang, Jun Hu, Haoming Lan +3
Journal of Hepatocellular Carcinoma27 Oct 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
Prognostic role of the naples prognostic score in advanced gastric cancer treated with immune checkpoint inhibitors: a retrospective multicenter study
Wanfen Tang, Lingfeng Ma, Ziyue Fu +7
Scientific Reports4 Oct 2026Peer-reviewedCC BY 4.0Full textGeneral medicineCrossref

Cite

BibTeX

@article{kang2026immune,
  title = {{Immune checkpoint inhibitors (ICIs) for second-line retreatment in esophageal cancer progressing after first-line immunotherapy: a single-center retrospective cohort study}},
  author = {Yixin Kang and Youjia Mi and Ce Zhang and Wenyao Li and Junqiang Yang and Jun Yao and Dianbao Zhang},
  journal = {Journal of thoracic disease},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13655824},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitors (ICIs) for second-line retreatment in esophageal cancer progressing after first-line immunotherapy: a single-center retrospective cohort study
AU  - Yixin Kang
AU  - Youjia Mi
AU  - Ce Zhang
AU  - Wenyao Li
AU  - Junqiang Yang
AU  - Jun Yao
AU  - Dianbao Zhang
PY  - 2026
DA  - 2026/09/10
JO  - Journal of thoracic disease
UR  - https://europepmc.org/article/PMC/PMC13655824
SN  - 2072-1439
SN  - 2077-6624
ER  -

Related

Cite